IRIS
BELTRAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.385
AS - Asia 2.518
EU - Europa 2.277
SA - Sud America 577
Continente sconosciuto - Info sul continente non disponibili 239
AF - Africa 96
OC - Oceania 8
Totale 10.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.247
RU - Federazione Russa 740
SG - Singapore 704
CN - Cina 671
IT - Italia 629
BR - Brasile 453
VN - Vietnam 341
HK - Hong Kong 250
GB - Regno Unito 221
BD - Bangladesh 168
IE - Irlanda 132
KR - Corea 128
FR - Francia 119
DE - Germania 105
IN - India 85
SE - Svezia 84
UA - Ucraina 72
FI - Finlandia 67
CA - Canada 51
MX - Messico 48
AR - Argentina 40
IQ - Iraq 30
ZA - Sudafrica 28
NL - Olanda 24
PL - Polonia 23
ID - Indonesia 21
KE - Kenya 21
TR - Turchia 18
CO - Colombia 17
EC - Ecuador 17
JP - Giappone 16
CL - Cile 14
PY - Paraguay 13
SA - Arabia Saudita 13
MA - Marocco 11
VE - Venezuela 11
ES - Italia 9
PE - Perù 9
PK - Pakistan 9
BE - Belgio 8
IR - Iran 8
AU - Australia 7
CR - Costa Rica 7
JM - Giamaica 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CI - Costa d'Avorio 6
NG - Nigeria 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
CZ - Repubblica Ceca 5
LT - Lituania 5
MY - Malesia 5
OM - Oman 5
PH - Filippine 5
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
KZ - Kazakistan 4
PT - Portogallo 4
SC - Seychelles 4
AT - Austria 3
BH - Bahrain 3
BW - Botswana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
NP - Nepal 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HT - Haiti 2
KG - Kirghizistan 2
KH - Cambogia 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
DM - Dominica 1
GE - Georgia 1
GF - Guiana Francese 1
IM - Isola di Man 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
Totale 9.857
Salva come PNG Salva come JPEG
Città #
Dallas 1.558
Singapore 410
San Jose 273
Ashburn 265
Moscow 246
Hong Kong 243
Council Bluffs 209
Milan 201
Hefei 200
Fairfield 151
Beijing 150
Southend 136
Dublin 129
Seoul 128
Santa Clara 114
Ho Chi Minh City 108
Los Angeles 85
Rome 80
Ann Arbor 76
Hanoi 72
Woodbridge 72
Houston 69
Seattle 69
Chandler 66
Lauterbourg 66
Jacksonville 55
New York 54
Wilmington 54
The Dalles 47
Cambridge 43
Columbus 42
Buffalo 40
Munich 40
São Paulo 35
Bengaluru 34
Dong Ket 27
Orem 27
San Nicola la Strada 26
Chicago 25
Princeton 24
Siena 24
Turku 24
Helsinki 23
Johannesburg 23
Mexico City 23
Denver 21
Düsseldorf 21
Brooklyn 19
Haiphong 19
Redondo Beach 19
Frankfurt am Main 18
Warsaw 18
Figino 17
Florence 17
Nanjing 17
Phoenix 16
Rio de Janeiro 16
Montreal 15
Brasília 14
Portsmouth 14
Turin 14
Bologna 13
Chennai 13
Naples 13
San Giuliano Terme 13
Tokyo 13
Baghdad 12
Biên Hòa 12
Da Nang 12
Dearborn 12
Lucca 12
Shanghai 11
Boardman 10
Palermo 10
Toronto 10
Atlanta 9
Boston 9
Lappeenranta 9
Nairobi 9
New Delhi 9
Bari 8
Brussels 8
Guangzhou 8
Lancaster 8
Porto Alegre 8
Tehran 8
Belo Horizonte 7
Dhaka 7
London 7
Mumbai 7
Ninh Bình 7
Quito 7
San Mateo 7
Abidjan 6
Can Tho 6
Charlotte 6
Curitiba 6
Goiânia 6
Hebei 6
Riyadh 6
Totale 6.491
Salva come PNG Salva come JPEG
Nome #
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines 454
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. 289
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 285
Prognostic significance of hyperuricemia in patients with acute heart failure 274
Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure 273
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 248
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer? 236
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 234
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application 233
Neuthrophil gelatinase associated lipocalin better predicts early acute kidney injury and outcome respect to bnp and cystatin c in acute heart failure patients 232
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function 232
Incidence of stroke in patients with hypertrophic cardiomyopathy implanted with a cardiac implantable electronic device 222
Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization 216
Natriuretic peptides and NGAL in heart failure: does a link exist? 213
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction 211
Current therapeutic strategies in cardiorenal syndrome 203
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 196
From gene mutations to biomechanical abnormalities and electrophysiological remodeling in hypertrophic cardiomyopathy: exploring the translational approach. 191
The potential role of natriuretic peptides in acute coronary syndrome stratification 178
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes 172
Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure 138
Chronotropic incompetence across heart failure categories 133
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 129
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer? 128
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF 125
Cardiac resynchronization therapy improves functional status and cognition 124
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 123
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care 120
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction 119
Clinical impact of renal dysfunction in heart failure 117
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 116
The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP 113
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 113
The Role of the Left Atrium: From Multimodality Imaging to Clinical Practice: A Review 112
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence 108
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease 108
Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting 107
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 103
Cardio-renal syndrome revealed increased neurohormonal activity, tubular and myocardial damage respect to heart failure patients with preserved renal function 102
Integrated Cardiorespiratory Rehabilitation and Its Impact on Cardio-Renal-Metabolic Profile After Cardiac Surgery 100
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 99
Combination Between Biomarkers and Echocardiographic Data for Prediction of Left Ventricular Reverse Remodelling in Cardiac Resynchronization Therapy 98
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 95
Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis 93
Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy 89
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 89
The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target 88
Relation of QRS duration to response to cardiac resynchronization therapy 86
The relevance of specific heart failure outpatient programs in the COVID era: An appropriate model for every disease 85
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time 85
Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block 84
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature 83
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 82
Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study 81
Continuous versus intermittent loop diuretics infusion dosing in acute heart failure: effects on renal function, outcome and BNP levels 79
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 77
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge 73
Different neurohormonal and inflammatory pattern in acute CRS respect to AHF patients with preserved renal function 71
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 69
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 68
Contemporary assessment of lung ultrasound, BNP and echocardiography for outcome prediction in patients with decompensated heart failure 67
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 65
COMPARISON OF DEMOGRAPHIC, CLINICAL, BIOCHEMICAL AND IMAGING AND IMAGING FINDINGS IN HYPERTROPHIC CARDIOMYOPATHY PROGNOSIS: A NETWORK META-ANALYSES 63
Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS study 63
The Role of Lung Ultrasound Scan in Different Heart Failure Scenarios: Current Applications and Lacks of Evidences 62
The Role of Multimodality Imaging in Pediatric Cardiomyopathies 60
Contemporary assessment of lung ultrasound, bnp and echocardiography predicts outcome in patients with acute heart failure independently to systolic dysfunction 60
ATRIOVENTRICULAR BLOCK, AN UNUSUAL CLINICAL PRESENTATION OF CALCIFIED BICUSPID AORTIC VALVE 58
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 57
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 57
Longitudinal function and right ventricular remodeling ratio in acute heart failure: a non invasive measurement of right dysfunction and outcome 53
Transient versus persistent worsening renal function during hospitalization in acute heart failure: different phenotypes for different outcome 50
Cardiac resynchronization therapy improves functional status and cognition at long term follow-up 49
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 48
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT 45
Usefulness of contemporary echo and bnp assessment during early hospitalization in patients with acute heart failure 43
Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis 43
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy 41
Plasma Neuthrophil Gelatinase associated Lipocalin (NGAL) predict worsening renal function and outcome in patients with acute decompensated heart failure 36
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated 35
The impact of surgical myectomy on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: Insights from Echo-CPET analysis 30
Functional capacity and neurocognitive profile: the effects of cardiac resynchronization therapy 29
Left bundle branch area pacing with stylet driven lead in third-degree atrioventricular block following Morrow surgery 28
The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases 28
Exercise induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study 25
Prognostic significance of asymptomatic hyperuricemia and allopurinol therapy in chronic systolic HF outpatients 22
Eosinophilic granulomatosis with polyangiitis, a new recurrent feature in an extremely rare disease 20
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 16
PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten 16
Prevalence of device-detected atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy 15
Incidental cardiac mass: Differential diagnosis, clinical approach and review of the literature,Massa cardiaca incidentale: Diagnosi differenziale, approccio clinico e revisione della letteratura 12
Totale 10.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022126 0 0 0 21 11 9 7 8 6 20 16 28
2022/2023266 16 18 36 30 30 48 6 20 20 6 7 29
2023/2024189 7 4 25 3 4 51 66 7 2 2 1 17
2024/20251.546 11 12 22 15 52 131 159 88 115 116 197 628
2025/20266.118 461 812 1.290 681 871 188 431 121 172 352 270 469
2026/2027791 255 157 343 36 0 0 0 0 0 0 0 0
Totale 10.100